Arteriocyte is now a part of Isto Biologics.
Cleveland, OH, May 2, 2014
Artericyte awarded FDA IDE approval to initiate clinical evaluation of MAGELLAN® Bio-Bandage™ in Acute Deep Partial Thickness Thermal Injuries . . .
Hopkinton, MA, December 6, 2013
Arteriocyte Medical Systems, Inc., applauds CMS for adding MAGELLAN® Bio-Bandage™ as an option for Medicare and Medicaid Patients with chronic wounds.
Cleveland, OH, September 26, 2013
Arteriocyte Awarded BARDA Contract Valued up to $101.1 Million for Advanced Development of Arteriocyte's MAGELLAN® BioBandageTM for Thermal Radiation Injury.
Hopkinton, MA, June 4, 2012
Arteriocyte Medical Systems, Inc. announced today approval by the U.S. Food and Drug Administration (FDA) to manufacture and distribute the Arteriocyte Medical Systems brand of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its MAGELLAN® Platelet Separation System.
Cleveland, OH, April 6, 2012
Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention on Wounded Warriors
Cleveland, OH, June 7, 2011
Arteriocyte and the US Army Institute of Surgical Research (USAISR) sign a CRADA to speed development of Cellular Therapies for Orthopaedic Trauma
Cleveland, OH, January 27, 2011
Cleveland, OH, May 20, 2009
Cleveland, OH, November 8, 2007
Arteriocyte Medical Systems Forms Strategic Partnership with Medtronic including Acquisition of the Magellan Platelet Rich Plasma Business
Cleveland, OH, October 25, 2007
Meetings & Events
Arteriocyte Medical Systems participates in and presents at multiple medical conferences each year. Check back here for regular updates.
2016 Meetings & Events
September 23, 2016 - Sorrento, Italy
ICCRA - International Congress on Cartilage Repair of the Ankle
October 6 - 7, 2016 - London, England
CCR Expo - Clinical + Cosmetic + Reconstructive
October 26 - 28, 2016 - Boston, MA
NASS - North American Spine Society
December 9 - 11, 2016 - Las Vegas
A4M - American Academy of Anti-Aging Medicine